Xeloda 500mg Tablet
Marketer
Roche Products India Pvt Ltd
Salt Composition
Capecitabine (500mg)
Overview Xeloda 500mg Tablet
Capecitabine 500mg tablets are indicated for treating breast, colorectal, and rectal cancers. Other uses may be determined by your physician. It's administered alone or alongside other medications as part of chemotherapy regimens. Consume this medication with food, within 30 minutes post-meal. Dosage and frequency are determined by your doctor, dependent on your condition and subject to change. Strict adherence to the prescribed regimen is crucial, as incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical guidance. Common side effects include nausea, vomiting, abdominal discomfort, weakness, and diarrhea. This medication can decrease white blood cell counts, increasing infection risk. Regular blood tests are vital to monitor blood cell counts, as well as liver, kidney, and uric acid levels. Inform your doctor about pre-existing liver or kidney conditions, and all other medications, especially those used to treat infections, before commencing treatment. Interactions with other drugs are possible; complete medication disclosure is essential. This medication is contraindicated during pregnancy and breastfeeding. Effective contraception is advised for both partners throughout treatment. A patient support program is accessible in India through Tata 1mg; contact your doctor or call 1800-102-1618 for further information.
Uses of Xeloda 500mg Tablet
Carcinoma of the breast and colorectal cancer
Major Benefits of Xeloda 500mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 500mg Xeloda tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with food.
Common Side effects of Xeloda 500mg Tablet:
- Vomiting
- Weakness
- Nausea
- Abdominal pain
- Diarrhea
- Blisters on fingers/feet
How to use Xeloda 500mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 500mg Xeloda tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.
How Xeloda 500mg Tablet works:
Capecitabine 500mg tablets are a cancer treatment. Metabolically activated to 5-fluorouracil, it disrupts the production of genetic material (DNA and RNA) within cancerous cells. This inhibition of cellular replication slows and ultimately halts cancerous growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Xeloda 500mg tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Capecitabine 500mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Capecitabine 500mg tablets are contraindicated during lactation. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Capecitabine 500mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.
KidneyCAUTION
Capecitabine 500mg tablets require careful administration in individuals with impaired renal function. Dosage modification of capecitabine 500mg tablets may be necessary. Physician consultation is advised. The use of capecitabine 500mg tablets is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Capecitabine 500mg tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Capecitabine 500mg tablets are contraindicated in individuals with severe renal dysfunction.
What if you forget to take Xeloda 500mg Tablet :
NA
Facts to Know About Xeloda 500mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Modified Deoxycytidine |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Metabolic Inhibitors |



